Cyr61/Ccn1 Regulates dCK and CTGF and Causes Gemcitabine Resistant Phenotype in Pancreatic Ductal Adenocarcinoma

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-18-0899